Variant report

Variant	rs10827885
Chromosome Location	chr10:20103805-20103806
allele	A/C
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	MXI1	chr10:20103634-20107079	IMR90	lung:	n/a	n/a

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr10:20102006..20103854-chr10:20105528..20107867,2	K562	blood:

Variant related genes	Relation type
PLXDC2	TF binding region

Extended variants
information (count: 36 )
Associated
traits (count: 0)

rSNPs within LD-proxies of this variant (count:28)

rs_ID	r²[population]
rs10764159	0.86[AMR][1000 genomes];0.95[EUR][1000 genomes]
rs10764164	0.85[AFR][1000 genomes];0.94[AMR][1000 genomes];0.92[EUR][1000 genomes];0.89[ASN][1000 genomes]
rs12257233	0.91[EUR][1000 genomes];0.97[ASN][1000 genomes]
rs1590963	0.80[ASN][1000 genomes]
rs1977539	0.94[AMR][1000 genomes];0.92[EUR][1000 genomes];0.94[ASN][1000 genomes]
rs2481936	0.87[AMR][1000 genomes];0.90[EUR][1000 genomes];0.94[ASN][1000 genomes]
rs2481937	0.87[EUR][1000 genomes];0.87[ASN][1000 genomes]
rs2481938	0.87[EUR][1000 genomes];0.86[ASN][1000 genomes]
rs2481939	0.90[EUR][1000 genomes];0.95[ASN][1000 genomes]
rs2884470	0.90[EUR][1000 genomes];0.94[ASN][1000 genomes]
rs333687	0.90[EUR][1000 genomes];0.95[ASN][1000 genomes]
rs333689	0.90[EUR][1000 genomes]
rs333691	0.90[EUR][1000 genomes];0.95[ASN][1000 genomes]
rs333692	0.91[EUR][1000 genomes];0.94[ASN][1000 genomes]
rs420898	0.87[EUR][1000 genomes];0.92[ASN][1000 genomes]
rs442830	0.85[EUR][1000 genomes]
rs447706	0.89[EUR][1000 genomes];0.94[ASN][1000 genomes]
rs4748612	0.87[ASN][1000 genomes]
rs6482065	0.80[AMR][1000 genomes];0.94[EUR][1000 genomes];0.94[ASN][1000 genomes]
rs7086438	0.94[AMR][1000 genomes];0.91[EUR][1000 genomes];0.89[ASN][1000 genomes]
rs7094033	0.95[EUR][1000 genomes];0.90[ASN][1000 genomes]
rs7906452	0.89[AFR][1000 genomes];0.93[AMR][1000 genomes];0.91[EUR][1000 genomes];0.88[ASN][1000 genomes]
rs7908480	0.83[ASN][1000 genomes]
rs7911243	0.84[ASN][1000 genomes]
rs7912855	0.94[AMR][1000 genomes];0.97[EUR][1000 genomes];0.91[ASN][1000 genomes]
rs7914865	0.82[AFR][1000 genomes];0.93[AMR][1000 genomes];0.90[EUR][1000 genomes];0.87[ASN][1000 genomes]
rs7914996	0.98[AMR][1000 genomes];0.91[EUR][1000 genomes];0.85[ASN][1000 genomes]
rs989767	0.96[EUR][1000 genomes];0.97[ASN][1000 genomes]

Variant overlapped rSNPs/rCNVs (count:8 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	nsv1049295	chr10:19740296-20509036	Weak transcription Enhancers Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh ZNF genes & repeats Bivalent/Poised TSS Strong transcription Bivalent Enhancer Genic enhancers Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	11 gene(s)	inside rSNPs	diseases
2	esv34306	chr10:19777069-20117944	Enhancers Flanking Active TSS Weak transcription Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Strong transcription ZNF genes & repeats Bivalent Enhancer Genic enhancers Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA	10 gene(s)	inside rSNPs	diseases
3	nsv1044794	chr10:20010269-20391329	Enhancers Weak transcription Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Strong transcription ZNF genes & repeats Genic enhancers Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA	7 gene(s)	inside rSNPs	diseases
4	nsv540510	chr10:20010269-20391329	Weak transcription Enhancers Genic enhancers Bivalent/Poised TSS Active TSS Bivalent Enhancer Strong transcription Flanking Bivalent TSS/Enh ZNF genes & repeats Flanking Active TSS Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA	7 gene(s)	inside rSNPs	diseases
5	nsv1038966	chr10:20010469-20391190	Enhancers Active TSS Flanking Active TSS Weak transcription Strong transcription Flanking Bivalent TSS/Enh ZNF genes & repeats Bivalent/Poised TSS Genic enhancers Bivalent Enhancer Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA	7 gene(s)	inside rSNPs	diseases
6	nsv540511	chr10:20010469-20391190	Enhancers Flanking Active TSS Weak transcription Strong transcription Active TSS ZNF genes & repeats Bivalent Enhancer Genic enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA	7 gene(s)	inside rSNPs	diseases
7	nsv1037055	chr10:20010469-20651965	Enhancers Bivalent/Poised TSS Weak transcription Genic enhancers ZNF genes & repeats Flanking Bivalent TSS/Enh Active TSS Strong transcription Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	8 gene(s)	inside rSNPs	diseases
8	nsv540512	chr10:20010469-20651965	Weak transcription Flanking Active TSS Enhancers Active TSS ZNF genes & repeats Strong transcription Bivalent/Poised TSS Flanking Bivalent TSS/Enh Genic enhancers Bivalent Enhancer Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	8 gene(s)	inside rSNPs	diseases

No data

Chromatin state (count:57 , 50 per page) page: 1 2

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr10:20100400-20104000	Weak transcription	Aorta	Aorta
2	chr10:20102000-20104400	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Male	--
3	chr10:20102400-20104000	Weak transcription	HMEC	breast
4	chr10:20102400-20104000	Weak transcription	NHEK	skin
5	chr10:20102800-20104400	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Female	--
6	chr10:20103400-20104000	Flanking Active TSS	H1 Cell Line	embryonic stem cell
7	chr10:20103400-20104000	Flanking Active TSS	HUES64 Cell Line	embryonic stem cell
8	chr10:20103400-20104000	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
9	chr10:20103400-20104200	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
10	chr10:20103400-20104400	Flanking Bivalent TSS/Enh	Monocytes-CD14+_RO01746	blood
11	chr10:20103400-20106400	Active TSS	Stomach Smooth Muscle	stomach
12	chr10:20103400-20109000	Active TSS	Brain Anterior Caudate	brain
13	chr10:20103400-20110200	Active TSS	Brain Hippocampus Middle	brain
14	chr10:20103600-20104000	Flanking Active TSS	H9 Derived Neuron Cultured Cells	ES cell derived
15	chr10:20103600-20104000	Flanking Active TSS	HUES48 Cell Line	embryonic stem cell
16	chr10:20103600-20104000	Flanking Bivalent TSS/Enh	iPS-18 Cell Line	embryonic stem cell
17	chr10:20103600-20104000	Flanking Bivalent TSS/Enh	iPS-20b Cell Line	embryonic stem cell
18	chr10:20103600-20104000	Bivalent Enhancer	Primary monocytes fromperipheralblood	blood
19	chr10:20103600-20104000	Enhancers	Adipose Nuclei	Adipose
20	chr10:20103600-20105600	Active TSS	ES-I3 Cell Line	embryonic stem cell
21	chr10:20103600-20107600	Active TSS	iPS-15b Cell Line	embryonic stem cell
22	chr10:20103800-20104000	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
23	chr10:20103800-20104000	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
24	chr10:20103800-20104000	Flanking Bivalent TSS/Enh	HUES6 Cell Line	embryonic stem cell
25	chr10:20103800-20104000	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
26	chr10:20103800-20104000	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
27	chr10:20103800-20104000	Flanking Bivalent TSS/Enh	Muscle Satellite Cultured Cells	--
28	chr10:20103800-20104000	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
29	chr10:20103800-20104000	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
30	chr10:20103800-20104000	Enhancers	Brain Substantia Nigra	brain
31	chr10:20103800-20104000	Bivalent/Poised TSS	Fetal Brain Male	brain
32	chr10:20103800-20104000	Enhancers	Fetal Intestine Large	intestine
33	chr10:20103800-20104000	Flanking Active TSS	Pancreatic Islets	Pancreatic Islet
34	chr10:20103800-20104000	Enhancers	Fetal Stomach	stomach
35	chr10:20103800-20104000	Flanking Bivalent TSS/Enh	NH-A	brain
36	chr10:20103800-20104200	Bivalent/Poised TSS	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
37	chr10:20103800-20104200	Flanking Active TSS	Breast Myoepithelial Primary Cells	Breast
38	chr10:20103800-20104200	Flanking Bivalent TSS/Enh	Primary hematopoietic stem cells	blood
39	chr10:20103800-20104200	Flanking Active TSS	Fetal Intestine Small	intestine
40	chr10:20103800-20104200	Flanking Active TSS	Fetal Kidney	kidney
41	chr10:20103800-20104200	Flanking Bivalent TSS/Enh	Fetal Lung	lung
42	chr10:20103800-20104400	Flanking Active TSS	Rectal Mucosa Donor 29	rectum
43	chr10:20103800-20105400	Active TSS	Skeletal Muscle Female	skeletal muscle
44	chr10:20103800-20106200	Active TSS	Ganglion Eminence derived primary cultured neurospheres	brain
45	chr10:20103800-20106400	Active TSS	Duodenum Mucosa	Duodenum
46	chr10:20103800-20107200	Active TSS	Rectal Mucosa Donor 31	rectum
47	chr10:20103800-20107400	Active TSS	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
48	chr10:20103800-20107800	Active TSS	Colon Smooth Muscle	Colon
49	chr10:20103800-20108000	Active TSS	Fetal Adrenal Gland	Adrenal Gland
50	chr10:20103800-20108000	Active TSS	Rectal Smooth Muscle	rectum

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links